Halloran Consulting Group

FDA Fast Track designations reach 20th year

Sunday, October 1, 2017

Twenty years after its inception, the FDA’s Fast Track designation program is going strong, with many signs that it has achieved its goal of bringing novel drugs to the market faster. Now, even with a new FDA Commissioner at the helm, the Fast Track program is unlikely to change substantially, although it may adjust to more explicitly address current areas of high-unmet medical need such as antibiotic resistance and cardiovascular disease.

[Read More]

Halloran Consulting Group expands Regulatory and Development Team

Friday, November 4, 2016

Halloran Consulting Group, a national consultancy guiding life science companies to optimize development and performance, has announced the expansion of its regulatory and development team with the hiring of additional, highly specialized consultants, Iva Toudjarska, Ph.D., MBA, as principal consultant, Amanda Ceres, MS, as senior consultant and Keri Siggers, Ph.D., as consultant II. Earlier this year, Michelle Rose, Ph.D., was hired as principal consultant, to further enhance the company’s ability to deliver regulatory strategies and services.

[Read More]

Halloran Consulting Group adds CMO Mark Weinberg

Tuesday, January 12, 2016

Halloran Consulting Group has expanded its strategic capabilities with the addition of Mark Weinberg, M.D., MBA, who will serve as chief medical officer (CMO) and managing director. The addition of Weinberg to Halloran’s advisory services creates a unique offering to life sciences companies seeking CMO expertise as a key part of an on-demand, integrated development team.

[Read More]